Tuberculous empyema: combined intrapleural therapy might be an alternative-Reference-Cited by-同舟云学术

Tuberculous empyema: combined intrapleural therapy might be an alternative

Published:2022-11-10 Issue: Volume: Page:e20220232
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:en
Short-container-title:J Bras Pneumol.

Author:

de Figueiredo Braga Colares1 Philippe¹^ORCID,Kiara Delgado Rivas1 Jennifer¹^ORCID,dos Santos Sciortino1 Amanda¹^ORCID,Karla Barbosa de Sales1 Roberta¹^ORCID,Ribeiro Teixeira1 Lisete¹^ORCID

Affiliation:

1. 1. Divisão de Pneumologia, Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP), Brasil.

Publisher

Sociedade Brasileira de Pneumologia e Tisiologia

Reference7 articles.

1. 1. Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusion. Respirology. 2019 Oct;24(10):962-971. https://doi.org/10.1111/resp.13673.

2. 2. Wen P, Wei M, Han C, He Y, Wang MS. Risk factors for tuberculous empyema in pleural tuberculosis patients. Sci Rep. 2019 Dec 20;9(1):19569. https://doi.org/10.1038/s41598-019-56140-4.

3. 3. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011 Aug 11;365(6):518-26. https://doi.org/10.1056/NEJMoa1012740.

4. 4. Luengo-Fernandez R, Penz E, Dobson M, Psallidas I, Nunn AJ, Maskell NA, et al. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial. Eur Respir J. 2019 Aug 1;54(2):1801550. https://doi.org/10.1183/13993003.01550-2018.

5. 5. Cheong XK, Abdul Hamid MF. Intrapleural alteplase and DNase for complex tuberculous pleurisy: a medical approach. Respirol Case Rep. 2021 Jan 3;9(2):e00706. https://doi.org/10.1002/rcr2.706. eCollection 2021 Feb.